Researchers can now identify cancer cells leading to tumor recurrence Cancer cells escaping tumors in the brain avoid surgery and create new recurrent tumors, but now researchers from the University of Copenhagen and Rigshospitalet have identified and characterized these cells. This can…
BRIC researcher participates in prime-time TV-show to explain how fundamental research can help cancer patients This year, Fena Ochs, is part of the “Knæk Cancer” fundraising show by the Danish Cancer Society and Danish TV-channel TV2. She shows how Knæk Cancer supports her research in breast- and ovarian cancer.
AI could predict breast cancer risk via ‘zombie cells’ Research from the University of Copenhagen shows that new AI technology is better at predicting the risk of breast cancer than current clinical benchmarks.
Now we know why children with Down’s syndrome have higher risk of Leukemia People with Down’s syndrome face a higher risk of developing Leukemia. Now researchers from the University of Copenhagen explain why, by identifying specific changes in blood cells of people with Down’s syndrome.
Tang J et al. Cell Rep Med 5: 101692, 2024 Team OF-BIOMARKER/ BIOENGINEERING/ OF-CANCER paper published
Vidal-Calvo EE et al. Nat Commun 15: 7553, 2024 Team OF-CANCER/ BIOENGINEERING/ DISCOVERY/ OF-BIOMARKER/ BIVAC paper published
Lars Engelholm awarded prestigious grant to advance innovative pan-cancer therapy Patients suffering from pancreatic cancer, as well as other cancer types, may face better treatment in the future. Researchers from BRIC and Rigshospitalet are awarded a 5 million DKK Frontier Grant by LF.
AI successfully helps detecting more breast cancers around Danish capital AI has helped to detect significantly more cases of breast cancer and reduce radiologist workloads. These are among the main conclusions of a new evaluation study from the University of Copenhagen and Capital Region of…
Now we know why successful treatment does not affect specific cancer cells The cells of a rare, deadly cancer are resistant to immunotherapy. Now researchers may have found the cause, paving the way for a new type of treatment.
Now we know why successful treatment does not affect specific cancer cells BRIC researchers reveal how glioblastoma cancer cells change appearance to avoid immunotherapy
“Working in a small company where I get insights into everything is fantastic” Sofie Liljewall is an industrial PhD Student at SOLID Therapeutics and CBMR. Sofie has a Master’s degree in molecular biotechnology engineering and did her Master's thesis in the Schwartz Group at CBMR.
New BRIC group leader seeks a multi-expertise approach in research Associate professor Julien Duxin is new group leader at BRIC. On June 10, 2024, Duxin-group from Center for Protein is moving to BRIC.
N. Meltem Daysal and co-author's new working paper featured on the NBER website. Do Medical Treatments Work for Work: Evidence from Breast Cancer Patients
Research project will develop intelligent robot that can screen for bowel cancer A new and innovative research project will study whether robots can be used to perform colonoscopies to ensure faster and less painful screening of patients. The research project is funded by the EU.
BRIC is hiring one or two new group leaders BRIC is hiring two new group leaders to establish and lead a new research group.
Germs can offset the effect of cancer therapy An infection with the bacteria Staphylococcus aureus tends to worsen the condition for patients with a specific lymphoma type. A Danish research team has identified the cause, providing hope for improved treatment.
Key Role of Epigenetic Information in Stem Cell Function unveiled Researchers revealed the importance of the transmission of epigenetic information through cell division for embryonic stem cells functionality. This has broad implications for aging, cancer, and regenerative medicine.
Medication in lower doses can save the healthcare system billions of DKK The effect of cancer drugs can often be preserved even when the labeled dose is significantly reduced. This can be used to spare cancer patients from side effects, free up staffing resources, and save the Danish…
Denmark funds BRIC cancer research projects From left: Fena Ochs, Jesper Andersen, Niels Behrendt Thanks to the generous donations made during the 2023 Knæk Cancer show last month, run by Danish Cancer Society and TV2, BRIC researchers Fena Ochs, Niels Behrend…